课题基金 / 基金详情

Promoting axon regneration and functional recovery after spinal cord injury

Promoting axon regneration and functional recovery after spinal cord injury
促进脊髓损伤后轴突再生和功能恢复
批准号:
7809817
负责人:
ZHIGANG HE
金额:
$44.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31

项目摘要

项目成果

ZHIGANG HE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Spinal cord injury disrupts the connections between the brain and spinal cord, often resulting in the loss of sensory and motor function below the lesion site. The most important reason for such permanent functional deficits is the failure of injured axons to regenerate after injury. In principle, the functional recovery could be achieved by two forms of axonal regrowth: the regeneration of lesioned axons which will reconnect with their original targets and the sprouting of spared axons that form new circuits and compensate for the lost function. Our recent studies reveal the activity of the mammalian target of rapamycin (mTOR) pathway, a major regulator of new protein synthesis, as a critical determinant of axon regrowth in the adult retinal ganglion neurons. This proposed study will focus on examining the possibility of whether manipulating the mTOR activity could promote the regrowth of descending corticospinal axons and restoration of lost functions after spinal cord injury. We expect that these experiments will provide important insights into the therapeutic potential of manipulating mTOR pathway in promoting axon regrowth and functional recovery after spinal cord injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism and Optimization of CBD-mediated analgesic effects
  • 批准号:
    10288673
  • 项目类别:
  • 资助金额:
    $13.22万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
KCC2 and spinal cord injury
  • 批准号:
    9884826
  • 项目类别:
  • 资助金额:
    $43.06万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
KCC2 and Spinal Cord Injury
  • 批准号:
    10599160
  • 项目类别:
  • 资助金额:
    $42.02万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
  • 批准号:
    10662464
  • 项目类别:
  • 资助金额:
    $67.09万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG HE
  • 依托单位:
海外基金